The Swiss marriage that never was
In 2001 Novartis thought it had cornered Roche, and a Swiss megamerger was on the cards. After 20 years of stalemate the awkward tie-up has ended.
Zimmer ditches slow-growing business to refocus
And the move will shake up the orthopaedic robotics scene.
Agios gets $1.8bn and a new focus
Selling its cancer drugs to Servier leaves Agios more reliant on mitapivat.
Philips sells the household goods and could spend on tech instead
Digital health is a core focus for Philips. Might more acquisitions be on the way?
